EMCDDA Home
  • EN
Search

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2010 or most recent year available

Part (v) Inpatient clients by secondary drug and primary drug

Secondary drugAmphetaminesMDMA and other derivatives
Opioids3575
Cocaine11114
Cannabis 122924
Alcohol56411
Stimulants (other than cocaine)1477
Hypnotics and sedatives3183
Hallucinogens714
Volatile192
Other substances 401
Total number of citations285671
 

Notes

Clients may report one primary drug, but more than one secondary drug

Countries providing data are: BE, BG, CZ, DK, IE, GR, FR, LU, HU, NL, AT, RO, SK, FI, SE, UK, HR, TR.

The number of treatment clients in each country is listed in Table TDI-7.

See also 'General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI by centre type.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Monday, 09 July 2012